Full Text
HP4 DRUG COSTS DEVELOPMENT AFTER PATENT EXPIRY IN THE THE NETHERLANDS

Abstract

Authors

C Boersma JM Bos RM Klok LTW de Jong-van den Berg MJ Postma

Back to Volume 7, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×